Update on the use of calcium antagonists on hypertension

Journal of Human Hypertension

Volumn 16, Issue , 2002, Pages S114-S117

  Hernandez Hernandez R ^a   Velasco, M ^b   Armas Hernandez M J ^a   Armas Padilla, M C ^a  

^a UNIVERSIDAD CENTROCCIDENTAL LISANDRO ALVARADO   (Venezuela)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

Calcium antagonists; Dihydropyridines

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; BENZOTHIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FELODIPINE; ISRADIPINE; LACIDIPINE; MANIDIPINE; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; PHENYLALKYLAMINE; VERAPAMIL;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CLASSIFICATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG USE; EDEMA; ELDERLY CARE; FLUSHING; GASTROINTESTINAL SYMPTOM; GINGIVA HYPERTROPHY; HEADACHE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LONG TERM CARE; POPULATION RESEARCH; SIDE EFFECT;

CALCIUM CHANNEL BLOCKERS; HUMANS; HYPERTENSION;

EID: 0036229594     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001355     Document Type: Article

References (28)

1. History of calcium antagonists
2. The mechanism of action of calcium antagonist relative to their clinical application
3. Farmacología clínica de los calcio antagonistas en la hipertensión arterial
4. Nifedipine: Individual responses and concentration-effect relationship
5. Comparison of verapamil and propranolol for the initial treatment of hypertension: Racial differences in response
6. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in the Hypertension Treatment (INSIGHT)
7. Potential modification of plaque behavior through the European lacidipine study on atherosclerosis
8. Role of calcium channel blockers in the treatment of hypertension
9. Current status of safety and efficacy of calcium channel blockers in cardiovascular disease: A critical analysis based on 100 studies
10. The risk of myocardial infarction associated with antihypertensive drug therapies
11. Long-term survival and use of antihypertensive medications in older persons
12. Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: A meta-analysis of randomised controlled trials
13. Blood Pressure Lowering Treatment Trialist's Collaboration. Effects of ACE inhibitors, calcium antagonists and other blood pressure-lowering drugs: Results of prospectively designed overviews of randomized trials
14. Calcium channel blockers: Do they have pleiotropic effects on atherosclerosis?
15. Calcium channel blockers: Their platelet actions
16. Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension
17. The pharmacokinetics of calcium antagonists that matter for practice
18. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial
19. Late decrease in body weight during antihypertensive treatment with fixed doses of calcium antagonists
20. The effects of missing a dose of enalapril versus amlodipine on ambulatory blood pressure
21. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension
22. The excess risk of treated end-stage renal disease in blacks in the United States
23. Raça e hipertenso arterial
24. Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes
25. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents
26. Antihypertensive treatment with diuretics in elderly patients
27. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP)
28. Treatment of isolated systolic hypertension in the elderly: The Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators